Accentia Biopharmaceuticals cuts loss as research costs drop

Accentia Biopharmaceuticals Inc. reported a net loss of $11.7 million, or 25 cents a share, for the three months ended June 30, compared to a net loss of $25 million, or 71 cents a share, in the same period a year ago. (ABPI)

Comments are closed.